The Infectious Disease Diagnostics Market in 2023 is US$ 25.37 billion, and is expected to reach US$ 39.59 billion by 2031 at a CAGR of 5.72%.
FutureWise Research published a report that analyzes Infectious Disease Diagnostics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Infectious Disease Diagnostics research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Infectious Disease Diagnostics Market Sample
Infectious Disease Diagnostics Market Segmentation:
By Product
- Reagents, Kits, and Consumables
- Instruments
- Software and Services
By Type of Testing
- Laboratory Testing
- POC Testing
By Technology
- Immunodiagnostics
- Clinical Microbiology
- PCR
- INAAT
- DNA Sequencing and NGS
- DNA Microarrays
- Other technologies
By Disease Type
- COVID-19
- HIV
- HAIs
- Hepatitis
- CT/NG
- HPV
- TB
- Influenza
- Other Infectious Diseases
By End User
- Diagnostic Laboratories
- Hospitals and Clinics
- Academic Research Institutes
- Other End Users
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Major players included in the Infectious Disease Diagnostics Market:
- Abbott Laboratories
- Hoffmann-La Roche Ltd
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Quidel Corporation
- Hologic, Inc.
- Siemens Healthineers AG
- Becton, Dickinson and Company
- PerkinElmer Inc.
- QIAGEN
- Grifols S.A.
- DiaSorin S.p.A
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Ortho Clinical Diagnostics
- Luminex Corporation
- Meridian Bioscience
- Genetic Signatures
- OraSure Technologies
Please visit full report of the Infectious Disease Diagnostics market @ Visit Infectious Disease Diagnostics Market
Competitive Landscape:
- Tier one players – market players with a significant share of the market
- Tier two players
- Players with rapid growth
- New Entries
FutureWise Key Takeaways:
- Prospects for growth
- Analysis of SWOT
- Key trends
- Key Data-points affecting market growth
Objectives of the Study:
- To provide report with an in-depth analysis of the Infectious Disease Diagnostics Market By Product, By Type of Testing, By Technology, By Disease Type, By End User and By Region
- To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
- Analysis and forecasting of micro-markets, as well as the scope of the market.
- To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
- To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Related Markets:
Flexible Delivery Model:
- With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
- Customization services are included with the purchase of any license type of report.
- Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
